SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIDE.L Share News (IDE)

  • There is currently no data for IDE

IDE Group Interim Non-Executive Chairman Dobbie Steps Down

Fri, 05th Oct 2018 09:28

LONDON (Alliance News) - IDE Group Holdings PLC said Friday Interim Non-Executive Chairman Bill Dobbie has stepped down from the board.

Non-Executive Director Andy Parker will replace him as Non-Executive Chairman with immediate effect.

Meanwhile, the cloud and managed IT services firm has appointed Max Royde, co-founder of fund management business Kestrel Partners LLP, as non-executive director.

Kestrel Partners is a shareholder of the company with an 18% stake.

IDE group shares were untraded Friday, last quoted at 2.35 pence.

Last Friday, IDE reported interim results which Executive Director Ian Smith said were the "worst" he had ever had to preside over, with no positive signs whatsoever.

Related News

TRADING UPDATES: SigmaRoc files patent; Griffin restarts operations
4 Nov 2022

TRADING UPDATES: SigmaRoc files patent; Griffin restarts operations

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News:

EARNINGS UPDATES: Harland & Wolff interim revenue climbs
30 Sep 2022

EARNINGS UPDATES: Harland & Wolff interim revenue climbs

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News:

IDE.L News

TRADING UPDATES: SigmaRoc files patent; Griffin restarts operations
4 Nov 2022

TRADING UPDATES: SigmaRoc files patent; Griffin restarts operations

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News:

EARNINGS UPDATES: Harland & Wolff interim revenue climbs
30 Sep 2022

EARNINGS UPDATES: Harland & Wolff interim revenue climbs

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News:

EARNINGS UPDATES: Hemogenyx hopes on cancer drug; IDE loss widens
29 Sep 2022

EARNINGS UPDATES: Hemogenyx hopes on cancer drug; IDE loss widens

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

TRADING UPDATES: ImmuPharma waits on FDA; IDE Group waits on audit
31 Aug 2022

TRADING UPDATES: ImmuPharma waits on FDA; IDE Group waits on audit

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

EARNINGS UPDATES: Bushveld loss widens; Scottish Investment assets up
30 Jun 2022

EARNINGS UPDATES: Bushveld loss widens; Scottish Investment assets up

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

TRADING UPDATES: Woodbois first-quarter revenue rises; Oriole upbeat
19 Apr 2022

TRADING UPDATES: Woodbois first-quarter revenue rises; Oriole upbeat

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

TRADING UPDATES: Petropavlovsk expects lower output; Keywords robust
27 Jan 2022

TRADING UPDATES: Petropavlovsk expects lower output; Keywords robust

TRADING UPDATES: Petropavlovsk expects lower output; Keywords robust